EPN 0.00% 2.4¢ epsilon healthcare limited

Ann: THC Quarterly Update and Appendix 4C, page-3

  1. 3,023 Posts.
    lightbulb Created with Sketch. 570
    Hallelujah, some clarity on THC licence situation......How hard was that to put across to SH's???
    We now all clear on what we're waiting/expecting.

    Regarding the 4C.
    Absolute dismal Receipts from customers of $576k, considering it it was over $1M for 2 consecutive qtrs not far back. Jason C too busy planning what to do with his handout windfall.
    With $578k in product manu & op costs, not even making a profit on CM division.
    Am I reading this wrong or just seems odd?

    No mention of separate receipts of import sales of Endoca product.

    $52k on advertising.....what we advertising? Don't have anything to market?

    Anyhow very positive on GC Facility & it's capabilities.

    Tick on enhancing prescriber education, long road, but most MC companies down this path.

    Hoping they bring some notable staff experience to team THC, notables with known international company worth would be nice, something THC lacking IMO.

    Mention of acquisition again, something in the pipeline a certainty.

    Overall disappointing 4C, but camouflaged with colorful business goings on. Like the update.
 
watchlist Created with Sketch. Add EPN (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.